Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

3.21
Delayed Data
As of 12:00pm ET
 +0.02 / +0.63%
Today’s Change
2.81
Today|||52-Week Range
5.35
-21.71%
Year-to-Date

Today’s Trading

Previous close3.19
Today’s open3.18
Day’s range3.18 - 3.22
Volume12,794
Average volume (3 months)57,310
Market cap$29.4M
Dividend yield--
Data as of 12:00pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+47.37%
Earnings growth (this year)+14.50%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.67%
P/E ratioNM
Price/Sales1.80
Price/Book0.64

Competitors

 Today’s
change
Today’s
% change
IMNPImmune Pharmaceutica...-0.02-5.45%
CERUCerulean Pharma Inc+0.01+0.95%
BIODBiodel Inc-0.00-1.10%
HTBXHeat Biologics Inc-0.07-4.86%
Data as of 12:14pm ET, 09/27/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$21.0M
Annual profit (last year)-$9.2M
Net profit margin-44.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs